Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Effects of THC on Emotional Memory Retrieval

Early Phase 1

Completed

Conditions: Healthy

Interventions: Drug: Placebo oral capsule
Drug: THC

First Posted Date: 2018-03-20

Last Posted Date: 2019-05-30

Lead Sponsor: University of Chicago

Target Recruit Count: 24

Registration Number: NCT03471585

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy

Phase 2

Terminated

Conditions: Head and Neck Cancer
Head and Neck Squamous Cell Carcinoma

Interventions: Drug: Pembrolizumab
Drug: Epacadostat

First Posted Date: 2018-03-13

Last Posted Date: 2020-01-27

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT03463161

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Stereotactic Body Radiotherapy (SBRT) Plus Immunotherapy for Cancer

Phase 1

Completed

Conditions: Cancer

Interventions: Drug: Nivolumab
Drug: Urelumab
Drug: Cabiralizumab
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2018-02-13

Last Posted Date: 2023-02-16

Lead Sponsor: University of Chicago

Target Recruit Count: 60

Registration Number: NCT03431948

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

PROGRESS Trial - Prophylactic Gabapentin for Relief of Symptoms and Improved Swallowing

Phase 2

Withdrawn

Conditions: Oropharyngeal Cancer
HPV-Related Squamous Cell Carcinoma

Interventions: Drug: Gabapentin

First Posted Date: 2018-02-06

Last Posted Date: 2024-07-31

Lead Sponsor: University of Chicago

Registration Number: NCT03423264

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Brexpiprazole in Borderline Personality Disorder

Phase 2

Completed

Conditions: Borderline Personality Disorder

Interventions: Drug: Placebo
Drug: Rexulti

First Posted Date: 2018-02-01

Last Posted Date: 2022-03-18

Lead Sponsor: University of Chicago

Target Recruit Count: 80

Registration Number: NCT03418675

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Prognosis--A Game-Based Intervention to Improve STEM Skills

Not Applicable

Completed

Conditions: Knowledge, Attitudes, Practice

Interventions: Behavioral: Prognosis

First Posted Date: 2018-01-31

Last Posted Date: 2024-08-12

Lead Sponsor: University of Chicago

Target Recruit Count: 31

Registration Number: NCT03416218

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Patient Centered Postpartum Contraception App

Completed

Conditions: Contraceptive Usage

First Posted Date: 2018-01-18

Last Posted Date: 2024-05-03

Lead Sponsor: University of Chicago

Target Recruit Count: 20

Registration Number: NCT03402217

Locations: 🇺🇸
University of Chicago Medical Center, Chicago, Illinois, United States

Tragus Stimulation to Prevent Atrial Fibrillation After Cardiac Surgery

Not Applicable

Completed

Conditions: Atrial Fibrillation

Interventions: Device: Parasym

First Posted Date: 2018-01-08

Last Posted Date: 2022-08-04

Lead Sponsor: University of Chicago

Target Recruit Count: 81

Registration Number: NCT03392649

Locations: 🇺🇸
The University of Chicago, Chicago, Illinois, United States

The Impact of a School-Based, Trauma-Informed CBT Intervention for Young Women

Not Applicable

Completed

Conditions: Anxiety
Anxiety Disorders
Behavioral Symptoms
Stress Disorders, Post-Traumatic
Depression
Mental Disorders
Trauma and Stressor Related Disorders
Stress Disorders, Traumatic
Wounds and Injuries

Interventions: Behavioral: Working on Womanhood (WOW)

First Posted Date: 2017-12-18

Last Posted Date: 2022-08-24

Lead Sponsor: University of Chicago

Target Recruit Count: 5106

Registration Number: NCT03376633

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Communication Bridge 2

Not Applicable

Completed

Conditions: Primary Progressive Aphasia

Interventions: Behavioral: Communication Bridge™
Behavioral: Evidence-Based Impairment Focused

First Posted Date: 2017-12-13

Last Posted Date: 2024-10-17

Lead Sponsor: University of Chicago

Target Recruit Count: 190

Registration Number: NCT03371706

Locations: 🇺🇸
The Healthy Aging & Alzheimer's Research Care Center (University of Chicago), Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy